⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 2, 2024Breastfeeding Medicine

Unique Kinetics of the Human Milk Antibody Response to JYNNEOS Vaccine for Prevention of Monkey Pox: A Case Study

Xiaoqi Yang Alisa Fox Claire DeCarlo Rebecca Powell

View Full Paper

Ask AI

Bookmark

Share

Abstract

JYNNEOS is a nonreplicating modified vaccinia Ankara vaccine currently licensed to prevent monkeypox infection, and its milk immunogenicity remains unstudied.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yang et al. (2024) studied this question.

synapsesocial.com/papers/68e56004e2b3180350efd2bd https://doi.org/10.1089/bfm.2024.0257

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1JYNNEOS vaccination induced short-lived neutralizing antibody responses to monkeypox virus in naive individuals2024 · 1 citations
2Pro-inflammatory cytokine profiles and neutralizing antibodies in JYNNEOS-vaccinated and mpox-diagnosed individuals2025 · 2 citations
3Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine — United States, May 2022–May 20242024 · 52 citations
4Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine — California, May 2022–May 2023Original Research · 2023 · 25 citations
5Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022Original Research · 2022 · 32 citations